5-(4-Chloro-phenyl)-2,3-dihydro-imidazo[2,1-a]isoquinoline

ID: ALA78668

PubChem CID: 10265702

Max Phase: Preclinical

Molecular Formula: C17H13ClN2

Molecular Weight: 280.76

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  Clc1ccc(C2=Cc3ccccc3C3=NCCN23)cc1

Standard InChI:  InChI=1S/C17H13ClN2/c18-14-7-5-12(6-8-14)16-11-13-3-1-2-4-15(13)17-19-9-10-20(16)17/h1-8,11H,9-10H2

Standard InChI Key:  KNRZKSWPBFNURY-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 20 23  0  0  0  0  0  0  0  0999 V2000
    6.8917   -2.0625    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.3792   -2.3667    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.9292   -1.4792    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.4167   -1.1542    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.8667   -2.0500    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.3792   -2.9667    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.8792   -1.4417    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.5292   -1.4792    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.8250   -1.9917    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.8167   -0.9625    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.4167   -2.3667    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.4167   -2.9667    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.7167   -1.4750    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.4167   -0.9542    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.4250   -1.9917    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.3167   -1.4750    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    5.3292   -2.3292    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.3667   -1.1250    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.8167   -2.0167    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.8375   -1.4125    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  1  0
  3  1  1  0
  4  3  2  0
  5  2  1  0
  6  2  2  0
  7  4  1  0
  8  3  1  0
  9  8  2  0
 10  8  1  0
 11  1  1  0
 12 11  1  0
 13 14  1  0
 14 10  2  0
 15  9  1  0
 16 13  1  0
 17  5  1  0
 18  7  1  0
 19 17  2  0
 20 18  2  0
  6 12  1  0
  5  7  2  0
 15 13  2  0
 20 19  1  0
M  END

Associated Targets(Human)

PTAFR Tchem Platelet activating factor receptor (2575 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Abelson 8.1 (129 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 280.76Molecular Weight (Monoisotopic): 280.0767AlogP: 3.91#Rotatable Bonds: 1
Polar Surface Area: 15.60Molecular Species: NEUTRALHBA: 2HBD:
#RO5 Violations: HBA (Lipinski): 2HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 7.13CX LogP: 3.66CX LogD: 3.48
Aromatic Rings: 2Heavy Atoms: 20QED Weighted: 0.77Np Likeness Score: -0.50

References

1. Houlihan WJ, Munder PG, Handley DA, Cheon SH, Parrino VA..  (1995)  Antitumor activity of 5-aryl-2,3-dihydroimidazo[2,1-a]isoquinolines.,  38  (2): [PMID:7830265] [10.1021/jm00002a004]

Source